VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 367 filers reported holding VANECK VECTORS ETF TR in Q3 2016. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,186,517 | -22.9% | 64,442 | -28.2% | 0.04% | -25.5% |
Q1 2024 | $2,836,852 | -2.0% | 89,717 | -3.9% | 0.05% | -11.3% |
Q4 2023 | $2,894,039 | +61.6% | 93,326 | +40.2% | 0.05% | +43.2% |
Q3 2023 | $1,790,861 | -45.7% | 66,550 | -39.2% | 0.04% | -43.9% |
Q2 2023 | $3,298,159 | +10.7% | 109,537 | +18.9% | 0.07% | +4.8% |
Q1 2023 | $2,979,209 | +71.4% | 92,093 | +51.9% | 0.06% | +57.5% |
Q4 2022 | $1,737,856 | +34.4% | 60,637 | +13.1% | 0.04% | +33.3% |
Q3 2022 | $1,293,000 | -65.9% | 53,598 | -61.3% | 0.03% | -63.4% |
Q2 2022 | $3,796,000 | -26.1% | 138,637 | +3.5% | 0.08% | -11.8% |
Q1 2022 | $5,136,000 | +68.5% | 133,929 | +40.8% | 0.09% | +75.5% |
Q4 2021 | $3,048,000 | -31.5% | 95,148 | -37.0% | 0.05% | -36.1% |
Q3 2021 | $4,451,000 | -13.7% | 151,028 | -0.5% | 0.08% | -9.8% |
Q2 2021 | $5,159,000 | +29.6% | 151,848 | +24.0% | 0.09% | +16.5% |
Q1 2021 | $3,981,000 | -31.5% | 122,499 | -24.0% | 0.08% | -35.8% |
Q4 2020 | $5,809,000 | -20.4% | 161,265 | -13.5% | 0.12% | -32.8% |
Q3 2020 | $7,298,000 | +34.0% | 186,364 | +25.5% | 0.18% | +29.8% |
Q2 2020 | $5,446,000 | +136.0% | 148,459 | +48.2% | 0.14% | +101.4% |
Q1 2020 | $2,308,000 | -33.5% | 100,169 | -15.4% | 0.07% | -18.6% |
Q4 2019 | $3,469,000 | +39.8% | 118,464 | +27.5% | 0.09% | +26.5% |
Q3 2019 | $2,481,000 | +32.2% | 92,893 | +26.6% | 0.07% | +33.3% |
Q2 2019 | $1,876,000 | +14.3% | 73,385 | +0.3% | 0.05% | +15.9% |
Q1 2019 | $1,641,000 | -4.8% | 73,200 | -10.4% | 0.04% | -18.5% |
Q4 2018 | $1,723,000 | -7.9% | 81,680 | -19.1% | 0.05% | +12.5% |
Q3 2018 | $1,871,000 | -29.0% | 101,022 | -14.5% | 0.05% | -33.3% |
Q2 2018 | $2,636,000 | -3.0% | 118,156 | -4.4% | 0.07% | +2.9% |
Q1 2018 | $2,717,000 | +15.0% | 123,637 | +21.7% | 0.07% | +14.8% |
Q4 2017 | $2,362,000 | -32.6% | 101,616 | -33.4% | 0.06% | -35.1% |
Q3 2017 | $3,504,000 | -20.4% | 152,617 | -23.5% | 0.09% | -22.3% |
Q2 2017 | $4,403,000 | +5.0% | 199,417 | +8.5% | 0.12% | +1.7% |
Q1 2017 | $4,193,000 | +57.0% | 183,802 | +44.0% | 0.12% | +52.6% |
Q4 2016 | $2,670,000 | -11.3% | 127,622 | +12.1% | 0.08% | -11.4% |
Q3 2016 | $3,009,000 | -34.7% | 113,838 | -31.6% | 0.09% | -35.8% |
Q2 2016 | $4,611,000 | – | 166,427 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |